Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
Pedro Nogueira Fontana(Faculdade de Medicina do ABC), Alzira Alves de Siqueira Carvalho(Centro Universitário Fundação Santo André), Vinicius Gomes Silva(Faculdade de Medicina do ABC), Natália Merten Athayde(Faculdade de Medicina do ABC), Pablo Vinícius Silveira Feitoza(Universidade Federal do Amazonas), Michel Moraes Soane, Carolina da Cunha Correia(Universidade de Pernambuco), Pedro José Tomaselli(Universidade de São Paulo), Ana Marina Dutra Ferreira da Silva(Faculdade de Medicina do ABC), Flávio Calil Petean(Universidade de Ribeirão Preto), Rafaela Hidalgo, Igor Dias Brockhausen, Cláudia Ferreira da Rosa Sobreira(Universidade de São Paulo), Rodrigo de Oliveira(Universidade de Ribeirão Preto), Natália B. Saraiva, Roseli Corazzini(Faculdade de Medicina do ABC), Cláudia Fideles, David Feder
Cited by 1
Related Papers
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
|The Lancet Neurology|2017|820
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia
|Nature Genetics|2019|592
Mitochondrial encephalomyopathy with coenzyme Q <sub>10</sub> deficiency
|Neurology|1997|196
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy
|Brain|2015|142
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
|Neuromuscular Disorders|2017|128